Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.
- NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_assertion description "[Loss of CD52 expression in RS most likely predicts resistance to alemtuzumab therapy, which is frequently used in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.
- NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_assertion evidence source_evidence_literature NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.
- NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_assertion SIO_000772 25511139 NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.
- NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_assertion wasDerivedFrom befree-20150227 NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.
- NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_assertion wasGeneratedBy ECO_0000203 NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP308439.RAR9LaB4NWgx1ow47V-rXKIcB2VPkjsg45tK7-BRNzFq4130_provenance.